Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 February 2023: Lab/In Vitro Research

Neutrophil-to-Platelet Ratio in Patients with Ulcerative Colitis Treated with Infliximab or Vedolizumab: A Retrospective, Single-Center Study in Poland

Marcin Warpechowski 1CD* , Jędrzej Warpechowski 2AEF , Anita Pieńkowska 2BEF , Szymon Sagała 2BEF , Robert Milewski 1CDE

DOI: 10.12659/MSM.938827

Med Sci Monit 2023; 29:e938827

Figure 5 A receiver operating characteristic curve was used to analyze the predictive ability of neutrophil-to-platelet ratio in patients treated with vedolizumab during the induction phase (weeks 2, 6, 14); AUC=0.795; 95% CI: 0.559–1; AUC – area under the curve, CI – confidence interval. The figure was created using Statistica version 13 (TIBCO Software, Inc.).

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750